MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation EV/EBITDA Ratio 2011-2026 | EW
Annual EV/EBITDA Ratio Edwards Lifesciences Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.2 | 36.1 | 36.3 | 30.6 | 24.4 | 23.9 | 23.6 | 24.1 | 14.3 | 22 | 25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.2 | 14.3 | 27.2 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
48.9 | $ 164.43 | -7.28 % | $ 12.3 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 10.89 | -5.47 % | $ 1.63 B | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
19.9 | $ 0.39 | 3.7 % | $ 40.1 M | USA |
 |
Abbott Laboratories
ABT
|
20.3 | $ 104.87 | 0.27 % | $ 183 B | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 34.01 | -3.76 % | $ 5.07 K | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 69.38 | -1.13 % | $ 103 B | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 9.21 | -1.9 % | $ 261 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 24.68 | 0.93 % | $ 209 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 35.31 | -3.64 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-68.6 | $ 56.44 | -5.79 % | $ 1.67 B |  Costa-rica |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.56 | 0.11 % | $ 122 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.93 | -4.0 % | $ 1.17 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 9.24 | -1.49 % | $ 712 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | 1.65 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
-0.459 | $ 2.19 | -3.74 % | $ 3.42 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Inogen
INGN
|
17.4 | $ 6.29 | -3.31 % | $ 167 M | USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 11.13 | -2.45 % | $ 1.5 B | USA |
 |
LivaNova PLC
LIVN
|
215 | $ 61.38 | -3.57 % | $ 3.35 B |  Britain |
 |
Medtronic PLC
MDT
|
24.4 | $ 87.08 | 0.14 % | $ 112 B | USA |
 |
MiMedx Group
MDXG
|
-669 | $ 3.92 | -0.51 % | $ 579 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.81 | -3.33 % | $ 371 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-0.00869 | $ 2.19 | -3.52 % | $ 128 M | Israel |
 |
InspireMD
NSPR
|
-1.11 | $ 1.6 | -7.51 % | $ 103 M | Israel |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
0.277 | - | 10.0 % | $ 610 K | USA |